Notice2023-15175
Draft Infection Control in Healthcare Personnel: Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients: Measles, Mumps, Rubella, and Varicella-Zoster Virus Sections
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 18, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), announces the opening of a docket to obtain comment on the Draft Infection Control in Healthcare Personnel: Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients: Measles, Mumps, Rubella, and Varicella-Zoster Virus Sections ("Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster Virus Sections"). The Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster Virus Sections updates the Guideline for infection control in health care personnel, 1998 ("1998 Guideline"), Part E: Epidemiology and Control of Selected Infections Transmitted Among Health Care Personnel and Patients, and its corresponding recommendations in Part II of the 1998 Guideline: "8. Measles;" "10. Mumps;" "15. Rubella;" and "21. Varicella." The updated recommendations in the Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster Virus Sections are intended for use by the leaders and staff of healthcare facilities and systems' Occupational Health Services (OHS), as further provided herein. These updated recommendations will help facilitate the provision of occupational infection prevention and control services to healthcare personnel (HCP) who have been exposed or infected and may be contagious to others in the workplace.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 136 (Tuesday, July 18, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 136 (Tuesday, July 18, 2023)]
[Notices]
[Pages 45906-45907]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-15175]
[[Page 45906]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0062]
Draft Infection Control in Healthcare Personnel: Epidemiology and
Control of Selected Infections Transmitted Among Healthcare Personnel
and Patients: Measles, Mumps, Rubella, and Varicella-Zoster Virus
Sections
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), in the
Department of Health and Human Services (HHS), announces the opening of
a docket to obtain comment on the Draft Infection Control in Healthcare
Personnel: Epidemiology and Control of Selected Infections Transmitted
Among Healthcare Personnel and Patients: Measles, Mumps, Rubella, and
Varicella-Zoster Virus Sections (``Draft Guideline: Measles, Mumps,
Rubella, and Varicella-Zoster Virus Sections''). The Draft Guideline:
Measles, Mumps, Rubella, and Varicella-Zoster Virus Sections updates
the Guideline for infection control in health care personnel, 1998
(``1998 Guideline''), Part E: Epidemiology and Control of Selected
Infections Transmitted Among Health Care Personnel and Patients, and
its corresponding recommendations in Part II of the 1998 Guideline:
``8. Measles;'' ``10. Mumps;'' ``15. Rubella;'' and ``21. Varicella.''
The updated recommendations in the Draft Guideline: Measles, Mumps,
Rubella, and Varicella-Zoster Virus Sections are intended for use by
the leaders and staff of healthcare facilities and systems'
Occupational Health Services (OHS), as further provided herein. These
updated recommendations will help facilitate the provision of
occupational infection prevention and control services to healthcare
personnel (HCP) who have been exposed or infected and may be contagious
to others in the workplace.
DATES: Written comments must be received on or before September 18,
2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0062 by either of the methods listed below. Do not submit comments by
email. CDC does not accept comments by email.
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Healthcare Infection Control Practices Advisory
Committee (HICPAC) Secretariat, Division of Healthcare Quality
Promotion, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329, Attn: Docket Number
CDC-2023-0062.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to <a href="http://regulations.gov">http://regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
FOR FURTHER INFORMATION CONTACT: Laura Wells, Division of Healthcare
Quality Promotion, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H16-2, Atlanta, Georgia 30329; Telephone:
(404) 639-4000.
SUPPLEMENTARY INFORMATION:
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data related to the
Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster Virus
Sections.
Please note that comments received, including attachments and other
supporting materials, are part of the public record and are subject to
public disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Therefore, do not include any information in your
comment or supporting materials that you consider confidential or
inappropriate for public disclosure. If you include your name, contact
information, or other information that identifies you in the body of
your comments, that information will be on public display. CDC will
review all submissions and may choose to redact, or withhold,
submissions containing private or proprietary information such as
Social Security numbers, medical information, inappropriate language,
or duplicate/near duplicate examples of a mass-mail campaign. Do not
submit comments by email. CDC does not accept comments by email.
Background
The Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster
Virus Sections, located in the ``Supporting & Related Material'' tab of
the docket, updates the Guideline for infection control in health care
personnel, 1998, Part E: Epidemiology and Control of Selected
Infections Transmitted Among Health Care Personnel and Patients, and
its corresponding recommendations in Part II of the 1998 Guideline:
``8. Measles;'' ``10. Mumps;'' ``15. Rubella;'' and ``21. Varicella.''
The 1998 Guideline provided information and recommendations for
Occupational Health Services (OHS) of healthcare facilities and systems
on the prevention of transmission of infectious diseases among
healthcare personnel (HCP) and patients and can be found at <a href="https://stacks.cdc.gov/view/cdc/11563">https://stacks.cdc.gov/view/cdc/11563</a>.
As described in the Executive Summary of this guideline (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/exec-summary.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/exec-summary.html</a>), in this document, ``OHS'' is used synonymously with
``Employee Health,'' ``Employee Health Services,'' ``Employee Health
and Safety,'' ``Occupational Health,'' and other such programs. OHS
refers to the group, department, or program that addresses many aspects
of health and safety in the workplace for HCP, including the provision
of clinical services for work-related injuries, exposures, and
illnesses. In healthcare settings, OHS addresses workplace hazards
including communicable diseases; slips, trips, and falls; patient
handling injuries; chemical exposures; HCP burnout; and workplace
violence.
This Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster
Virus Sections update is part of a larger guideline update: Infection
Control in Healthcare Personnel. Part I, Infrastructure and Routine
Practices for Occupational Infection Prevention and Control Services
(2019), and the Diphtheria, Group A Streptococcus, Meningococcal
Disease, Pertussis, and Rabies sections of Part II, Epidemiology and
Control of Selected Infections Transmitted Among Healthcare Personnel
and Patients (2022) are complete and have been published on the CDC
Infection Control Guideline website: <a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html</a>. The Draft
Guideline: Measles, Mumps, Rubella, and Varicella-Zoster Virus
Sections, once finalized, is intended for use by the leaders and staff
of OHS to guide the management of exposed or infected HCP who may be
contagious to others in the workplace. The draft recommendations in
Draft Guideline: Measles, Mumps, Rubella, and Varicella-Zoster Virus
Sections update the 1998 recommendations with current guidance on the
management of HCP exposed to or potentially infected with measles,
mumps, rubella, or varicella-zoster virus, focusing on postexposure
management, including postexposure
[[Page 45907]]
prophylaxis, for exposed HCP and work restrictions for exposed or
infected HCP.
Since 2015, the Healthcare Infection Control Practices Advisory
Committee (HICPAC) has worked with national partners, academicians,
public health professionals, healthcare providers, and other partners
to develop Infection Control in Healthcare Personnel (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html</a>) as a segmental update of the 1998 Guideline. HICPAC is a
Federal advisory committee appointed to provide advice and guidance to
HHS and CDC regarding the practice of infection control and strategies
for surveillance, prevention, and control of healthcare-associated
infections, antimicrobial resistance, and related events in United
States healthcare settings. HICPAC includes representatives from public
health, infectious diseases, regulatory and other Federal agencies,
professional societies, and others impacted. Draft Guideline: Measles,
Mumps, Rubella, and Varicella-Zoster Virus Sections, once finalized,
will be the next sections to be posted to the Infection Control in
Healthcare Personnel website.
The updated draft recommendations in Draft Guideline: Measles,
Mumps, Rubella, and Varicella-Zoster Virus Sections are informed by
reviews of the 1998 Guideline; CDC resources (e.g., CDC infection
control website), guidance, and guidelines, as noted more specifically
in the draft document; and new scientific evidence, when available. CDC
is seeking comments on the Draft Guideline: Measles, Mumps, Rubella,
and Varicella-Zoster Virus Sections. Please provide references to new
evidence and justification to support any suggested revisions or
additions. This Draft Guideline: Measles, Mumps, Rubella, and
Varicella-Zoster Virus Sections is not a Federal rule or regulation.
Dated: July 13, 2023.
Tiffany Brown,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2023-15175 Filed 7-17-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on July 18, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.